Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 465

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 2
Chunk 465
---
 A common stock, $0.001 par value, 100,000,000 shares authorized, 8,979,204 and 5,588,298 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 
     8,979  
     5,588 
  
    Convertible class B common stock, $0.001 par value, 5,000,000 shares authorized, 833,334 shares issued and outstanding 
     833  
     833 
  
    Common stock, value 
     833  
     833 

    Additional paid-in capital 
     11,692,952  
     9,071,745 
  
    Accumulated deficit 
     (8,824,193) 
     (5,064,955)
  
    Total stockholders’ equity 
     2,878,571  
     4,013,211 

    Total liabilities and stockholders’ equity 
    $3,679,332  
    $4,923,283 

See
accompanying notes to audited financial statements.

F-3

SYRA
HEALTH CORP.

STATEMENTS
OF OPERATIONS

    2024  
    2023 

    For the Year Ended 

    2024  
    2023 

    Net revenues 
    $7,982,082  
    $5,515,144 
  
    Cost of services 
     6,329,119  
     4,103,244 
  
    Gross profit 
     1,652,963  
     1,411,900 

    Operating expenses: 

    Salaries and benefits 
     2,718,743  
     2,292,295 
  
    Professional services 
     606,051  
     586,463 
  
    Research and development expenses 
     585,146  
     240,048 
  
    Selling, general and administrative expenses 
     1,445,170  
     1,131,922 
  
    Depreciation 
     62,738  
     48,771 
  
    Total operating expenses 
     5,417,848  
     4,299,499 

    Operating loss 
     (3,764,885) 
     (